Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-052258

Options or other derivatives

  • Chief Medical Officer acquired 104,890 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Daugherty Frank Joseph Chief Medical Officer 2024-12-24 Grant or award · Stock Options +104,890 209,780 D: show line 1 in the form
Loading xslF345X05/ownership.xml…